BioCentury
ARTICLE | Company News

Cognition names Moch CEO

October 28, 2016 7:00 AM UTC

Neuroscience therapeutics company Cognition Therapeutics Inc. (Pittsburgh, Pa.) hired Kenneth Moch as president and CEO, replacing Hank Safferstein. Moch, who was managing partner of consulting firm Salutramed Group, was president and CEO of Chimerix Inc. (NASDAQ:CMRX). ...